Omega Healthcare Investors (NYSE:OHI) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday, The Fly reports.
OHI has been the subject of a number of other research reports. Bank of America upgraded Omega Healthcare Investors from an “underperform” rating to a “neutral” rating and set a $35.00 price objective for the company in a report on Friday, November 16th. ValuEngine upgraded Omega Healthcare Investors from a “hold” rating to a “buy” rating in a report on Tuesday, November 20th. Mitsubishi UFJ Financial Group upgraded Omega Healthcare Investors from a “neutral” rating to an “overweight” rating and upped their price objective for the company from $34.00 to $40.00 in a report on Friday, January 4th. TheStreet upgraded Omega Healthcare Investors from a “c” rating to a “b-” rating in a report on Thursday, November 8th. Finally, Zacks Investment Research upgraded Omega Healthcare Investors from a “sell” rating to a “hold” rating in a report on Wednesday, October 31st. Seven analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $33.33.
NYSE OHI opened at $39.37 on Thursday. The stock has a market capitalization of $7.96 billion, a P/E ratio of 11.93, a P/E/G ratio of 6.42 and a beta of 0.52. The company has a quick ratio of 4.17, a current ratio of 4.17 and a debt-to-equity ratio of 1.21. Omega Healthcare Investors has a 12 month low of $25.05 and a 12 month high of $40.30.
Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings data on Monday, November 5th. The real estate investment trust reported $0.28 EPS for the quarter, missing analysts’ consensus estimates of $0.74 by ($0.46). The company had revenue of $192.30 million during the quarter, compared to the consensus estimate of $194.40 million. Omega Healthcare Investors had a net margin of 31.91% and a return on equity of 7.32%. The company’s revenue for the quarter was down .9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.79 EPS. On average, equities research analysts predict that Omega Healthcare Investors will post 2.99 EPS for the current year.
In other Omega Healthcare Investors news, insider Michael Ritz sold 2,000 shares of the stock in a transaction dated Monday, November 19th. The stock was sold at an average price of $35.50, for a total value of $71,000.00. Following the completion of the sale, the insider now directly owns 8,076 shares in the company, valued at $286,698. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Steven J. Insoft sold 50,000 shares of the stock in a transaction dated Thursday, January 31st. The stock was sold at an average price of $40.00, for a total value of $2,000,000.00. The disclosure for this sale can be found here. Insiders sold 86,000 shares of company stock valued at $3,321,750 over the last 90 days. Corporate insiders own 1.65% of the company’s stock.
Institutional investors have recently made changes to their positions in the business. Enlightenment Research LLC bought a new stake in shares of Omega Healthcare Investors in the fourth quarter worth about $49,000. Bedel Financial Consulting Inc. acquired a new position in shares of Omega Healthcare Investors during the fourth quarter worth about $51,000. Oregon Public Employees Retirement Fund boosted its position in shares of Omega Healthcare Investors by 3,415.0% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 2,757,904 shares of the real estate investment trust’s stock worth $78,000 after buying an additional 2,679,443 shares during the period. KBC Group NV acquired a new position in shares of Omega Healthcare Investors during the fourth quarter worth about $128,000. Finally, Belpointe Asset Management LLC acquired a new position in shares of Omega Healthcare Investors during the third quarter worth about $131,000. Institutional investors own 73.46% of the company’s stock.
Omega Healthcare Investors Company Profile
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Featured Story: Cost of Debt
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.